Healthcare-Market Fit Lab (PMF for Healthcare & Life Sciences)
Arvita Tripati
I make healthtech products buyable.
Healthcare has a hundred markets. Most founders pick the wrong one first.
Healthtech founders are getting positive signals that never turn into revenue.
Clinicians love the product. Advisors say the TAM is enormous. You might have a pilot running. And still, nothing is closing.
So you fix the pitch. Hire a sales advisor. Ask another advisor which buyer to prioritize and get a different answer.
The problem usually is not the pitch. It is that the market you chose cannot adopt what you built: not at this stage, not with your current evidence, not through the procurement and governance process your buyer actually requires.
The buyer is not the user. The budget holder is not the champion. The evidence that excites a clinician is not the evidence that gets a contract signed.
Healthcare-Market Fit gives you a framework to diagnose which market can actually buy, before you build the wrong proof strategy or spend another year in the wrong direction.
What you’ll learn
By the end of the lab, you will have a US-entry package made up of six practical artifacts.
Build a US Beachhead Memo that names the buyer, pain, budget, trigger, and path to purchase.
Clarify what you can safely say, what proof each claim requires, and which claims need to change.
Prioritize the clinical, economic, workflow, technical, and operational proof gaps to close.
Create a Buyer Trust Packet covering privacy, security, data, AI governance, procurement, and implementation.
Define the pilot owner, scope, success metrics, buyer responsibilities, and conversion criteria before the pilot starts.
Build a US Entry Diligence Pack and 30/60/90-day roadmap for buyers, investors, and partners.
Learn directly from Arvita
Arvita Tripati
VP operator. EIR. 30+ regulated AI products shipped. AliveCor, LabCorp, Vineti, Korio, Clip Health
Who this course is for
Wellness & Healthtech founders getting interest but not traction who aren't sure if the problem is the product, the pitch, or the market.
Medtech & TechBio founders getting interest but not traction who aren't sure if the problem is the product, the pitch, or the market.
You have a product, prototype, or home-market sales who need to understand what US buyers, investors, partners, and regulators will expect.
What's included
Live sessions
Learn directly from Arvita Tripati in a real-time, interactive format.
Lifetime access
Go back to course content and recordings whenever you need to.
Community of peers
Stay accountable and share insights with like-minded professionals.
US-entry package.
US Beachhead Memo, Regulatory and Claims Map, Evidence and Adoption Plan, Buyer Trust Packet, Pilot-to-Contract Plan, and US Entry Diligence Pack with 90-Day Roadmap.
Maven Guarantee
Your purchase is backed by the Maven Guarantee.
Course syllabus
Week 1
Jul
20
Week 1: Who is the first US buyer?
Mon 7/202:00 PM—6:00 PM (UTC)
Who is the first US buyer?
Week 2
Jul
27
What can you safely claim?
Mon 7/272:00 PM—6:00 PM (UTC)
What can you safely claim?
Schedule
Live sessions
8 hrs
Mon, Jul 20
2:00 PM—6:00 PM (UTC)
Mon, Jul 27
2:00 PM—6:00 PM (UTC)
Mon, Aug 3
2:00 PM—6:00 PM (UTC)
Projects
10 hrs
Frequently asked questions
Maven for Teams
Reimbursement
Get your company to pay
Everything L&D needs: email template, receipts, and certificate of completion.
Get reimbursedPrivate cohort
Run a cohort for your org
A dedicated cohort with a custom schedule and curriculum, tailored to your team.
Book a private cohort$2,500
USD